(Q51478902)

5 April 2018

title

Calcific uremic arteriolopathy treated with cinacalcet, paricalcitol, and autologous growth factors. (English)

1 reference

5 April 2018

author name string

Despoina Kakagia

1

1 reference

5 April 2018

Pelagia Kriki

2

1 reference

5 April 2018

Elias Thodis

3

1 reference

5 April 2018

Athanasios Roumeliotis

4

1 reference

5 April 2018

Vassilios Vargemezis

5

1 reference

5 April 2018

publication date

1 March 2011

1 reference

5 April 2018

Journal of cutaneous medicine and surgery

published in

1 reference

5 April 2018

volume

15

1 reference

5 April 2018

issue

2

1 reference

5 April 2018

page(s)

121-124

1 reference

5 April 2018

Calcific uremic arteriolopathy: advances in pathogenesis and treatment

cites work

1 reference

https://api.crossref.org/works/10.2310%2F7750.2011.10052

Pivotal role of paricalcitol in the treatment of calcific uremic arteriolopathy in the presence of a parathyroid adenoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F7750.2011.10052

Nonclassical aspects of differential vitamin D receptor activation: implications for survival in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F7750.2011.10052

Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F7750.2011.10052

Rigorous Vibrio vulnificus soft tissue infection of the lower leg in a renal transplant patient managed by vacuum therapy and autologous growth factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2310%2F7750.2011.10052

21 January 2018

Identifiers

DOI

10.2310/7750.2011.10052

1 reference

5 April 2018

1 reference

5 April 2018